Skip to main content

Advertisement

Table 5 Multivariable analysis of the total CD34+ cell yield in 39 patients with high-risk non-Hodgkin’s lymphoma

From: Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

Parameter Total CD34+ cell yield (×106 cells/kg body weight)
B 95% CI P value
Percentage of CD34+ cells in peripheral blood on the first day of apheresis 1.886 1.104 to 2.669 <0.001
Previous chemotherapy cycles −0.07 −1.386 to 1.245 0.914
Duration of rhG-CSF support −0.829 −1.685 to 0.028 0.058
Time from mobilization to apheresis −0.736 −1.544 to 0.073 0.073
Age −3.718 −6.521 to −0.914 0.011
  1. CI confidence interval. Other abbreviation as in Table 2